DUPHALAC Oral solution Ref.[50851] Active ingredients: Lactulose

Source: Health Products Regulatory Authority (IE)  Revision Year: 2022  Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

4.1. Therapeutic indications

Constipation.

Hepatic encephalopathy (HE): treatment and prevention of hepatic coma or precoma.

4.2. Posology and method of administration

The lactulose solution may be administered diluted or undiluted.

A single dose of lactulose should be swallowed in one and should not be kept in the mouth for an extended period of time.

The posology should be adjusted according to the individual needs of the patient. In case of a single daily dose, this should be taken at the same time e.g. during breakfast. During the therapy with laxatives it is recommended to drink sufficient amounts of fluids (1.5-2 litres, equal to 6-8 glasses) during the day.

Dosing in Constipation

Lactulose may be given as a single daily dose or in two divided doses. After a few days the starting dosage may be adjusted to the maintenance dose based upon treatment response.

Several days (2-3 days) of treatment may be needed before treatment effect occurs.

 Starting dose dailyMaintenance dose daily
Adults and adolescents15-45 ml15-30 ml
Children (7-14 years) 15 ml10-15 ml
Children (1-6 years) 5-10 ml5-10 ml
Infants under 1 yearUp to 5 mlUp to 5 ml

Method of Administration

Oral use.

For Duphalac in bottles the measuring cup may be used to administer the appropriate dose.

Dosing in Hepatic Encephalopathy (HE)

Adults

For oral administration.

Starting Dose Maintenance Dose
3 to 4 times daily 30-45 mlStarting dose may be adjusted to the maintenance dose to achieve 2-3 soft stools per day

Special Populations

Paediatric population

The safety and efficacy of Duphalac in children (newborn to 18 years of age) with Hepatic Encephalopathy have not been established. No data is available.

Elderly patients and patients with renal or hepatic insufficiency

No special dosage recommendations exist, since systemic exposure to lactulose is negligible.

4.9. Overdose

If the dose is too high the following may occur:

Symptom: diarrhoea, loss of electrolytes and abdominal pain.

Treatment: cessation of treatment or dose reduction. Extensive fluid loss by diarrhoea or vomiting may require correction of electrolyte disturbances.

6.3. Shelf life

Three years.

6.4. Special precautions for storage

This medicinal product does not require any special storage conditions.

6.5. Nature and contents of container

Opaque white multidose bottles of HDPE with a polypropylene screw cap containing 300 or 1000 ml, with a polypropylene measuring cup.

The graduations on the measuring cup are: 2.5ml, 5ml, 10ml, 15ml, 20ml, 25ml and 30ml.

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.